急性肾功能衰竭治疗的研究近况

[1] Changing acute renal failure treatment from interm ittent hemodialysis to continuous hemofiltration: impact on azotem ic control. Bellomo R,Farmer M,Bhonagiri S,et al. International Journal of Artificial Organs . 1999

[2] Anaritideinacutetubularnecrosis.Aur iculinAnaritideAcuteRenalFailureStudy Group. AllgrenRL,MarburyTC,PahmanSN,et al. The New England Journal of Medicine . 1997

[3] Con tinuousrenalreplacementtherapyimprovesre nalrecoveryfromacuterenalfailure:〔La therapiecontinuederemplacementrenalame liorelarecuperationrenalesuivantuneinsuff isancerenaleaigue〕. JackaMJ,IvancinovaX,GibneyRT. CanJAnaesth . 2005

[4] A comparisonofcontinuousrenalreplacement therapytointermittentdialysisinthemanage mentofrenalinsufficiencyintheacutelyⅢsurgicalpatient. WaldropJ,CirauloDL,MilnerTP,etal. AmSurg . 2005

[5] Nephroprotective effects of pentoxifylline in experimentalmyoglobinuric acute renal failure. Savic V,V lahovic P,D jordjevic V,et al. Pathologie Biologie . 2002

[6] Mannitol , furosemide,and dopamine infusion in postoperative renal failure complicating cardiac surgery. Sirivella S,Gielchinsky I,Parsonnet V. The Annals of Thoracic Surgery . 2000

[7] Renaldose ( low-dose) dopam ine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous. Power DA,Duggan J,Brady HR. C lin Exp Pharmacol Physiol Suppl . 1999

[8] Triiodothyronine stimulates renal ep idermal growth factor expression in adult rat. Rogers SA,M iller SB,Hammerman MR. American Journal of Physiology . 1995

[9] Pre- or post- treatment with hepatocyte growth factor prevents glycerol- induce acute renal failure. Nagano T,Mori-Kudo I,Kawamura T,et al. Renal Failure . 2004

[10] Hepatocyte growth factor: renotrop ic role and potential therapeutics for renal disease. MatsumotK,Nakamura T. Kidney International . 2001

[1] Changing acute renal failure treatment from interm ittent hemodialysis to continuous hemofiltration: impact on azotem ic control. Bellomo R,Farmer M,Bhonagiri S,et al. International Journal of Artificial Organs . 1999

[2] Anaritideinacutetubularnecrosis.Aur iculinAnaritideAcuteRenalFailureStudy Group. AllgrenRL,MarburyTC,PahmanSN,et al. The New England Journal of Medicine . 1997

[3] Con tinuousrenalreplacementtherapyimprovesre nalrecoveryfromacuterenalfailure:〔La therapiecontinuederemplacementrenalame liorelarecuperationrenalesuivantuneinsuff isancerenaleaigue〕. JackaMJ,IvancinovaX,GibneyRT. CanJAnaesth . 2005

[4] A comparisonofcontinuousrenalreplacement therapytointermittentdialysisinthemanage mentofrenalinsufficiencyintheacutelyⅢsurgicalpatient. WaldropJ,CirauloDL,MilnerTP,etal. AmSurg . 2005

[5] Nephroprotective effects of pentoxifylline in experimentalmyoglobinuric acute renal failure. Savic V,V lahovic P,D jordjevic V,et al. Pathologie Biologie . 2002

[6] Mannitol , furosemide,and dopamine infusion in postoperative renal failure complicating cardiac surgery. Sirivella S,Gielchinsky I,Parsonnet V. The Annals of Thoracic Surgery . 2000

[7] Renaldose ( low-dose) dopam ine for the treatment of sepsis-related and other forms of acute renal failure: ineffective and probably dangerous. Power DA,Duggan J,Brady HR. C lin Exp Pharmacol Physiol Suppl . 1999

[8] Triiodothyronine stimulates renal ep idermal growth factor expression in adult rat. Rogers SA,M iller SB,Hammerman MR. American Journal of Physiology . 1995

[9] Pre- or post- treatment with hepatocyte growth factor prevents glycerol- induce acute renal failure. Nagano T,Mori-Kudo I,Kawamura T,et al. Renal Failure . 2004

[10] Hepatocyte growth factor: renotrop ic role and potential therapeutics for renal disease. MatsumotK,Nakamura T. Kidney International . 2001